Market Place
Sourcing Support
Totus Medicines Appoints Simon Harnest as Chief Financial Officer
28 Jan 2025 //
GLOBENEWSWIRE
Totus Completes Ph 1 Study Of TOS-358, Appoints Zelanna CMO
10 Jan 2025 //
GLOBENEWSWIRE
Totus Medicines, Lilly Announce Multi-Target Research Collaboration
16 May 2024 //
GLOBENEWSWIRE
Totus Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
PR NEWSWIRE
Totus closes $66M Series B to fund early-stage PI3Ka inhibitor, names new CEO
15 Dec 2023 //
ENDPTS
Totus Medicines Appoints John Maraganore to Scientific Advisory Board
19 Oct 2023 //
PR NEWSWIRE
Totus Medicines CEO to Chair Next-Generation Undruggable
27 Sep 2023 //
PR NEWSWIRE
Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358
13 Apr 2023 //
PR NEWSWIRE
Totus Medicines Appoints Dr. Lewis Cantley, Dr. Hope Rugo, & Dr. Josep Tabernero
12 Apr 2023 //
PR NEWSWIRE
Totus Medicines Announces Presentations at AACR Annual Meeting
10 Apr 2023 //
PR NEWSWIRE
Totus Medicines Announces Poster Presentation for TOS-358 at Symposium
27 Oct 2022 //
PRNEWSWIRE
Totus Medicines Announces Tom Hughes as Board Chair & Scientific Advisory Board
05 May 2022 //
PRNEWSWIRE
Totus Medicines Hires Corporate Strategy Leader Laura Miller
23 Mar 2022 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.